Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of Docetaxel + Gemcitabine in Locally Advanced Breast Cancer
KCT0000312Phase 2Recruiting
- Sponsor
- Yuhan
- Start
- Dec 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, gemcitabine in breast cancer, sponsored by Yuhan. Started Dec 2011; status: recruiting.
02
Drugs
docetaxelgemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on KCT0000312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000312.